Literature DB >> 7796418

A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence.

J A Byrne1, C Tomasetto, J M Garnier, N Rouyer, M G Mattei, J P Bellocq, M C Rio, P Basset.   

Abstract

We describe a differential screening method for cDNA libraries which used a combination of subtracted and PCR-amplified cDNA probes, and which can be applied to the selection of genes expressed in multiple tissues. This technique was used to identify genes commonly overexpressed in breast and basal cell carcinomas. These represent stromally dependent, invasive tumors with and without metastatic capacity. Thus, this screening sought to identify genes involved in the early stages of tumor progression. We identified a total of 16 genes, including c-erbB-2 and tissue inhibitor of metalloproteinases 3 whose products have been implicated in tumorigenesis or invasion. We also identified a novel sequence (D52) showing little homology with others described in any species, which maps to the human chromosomal band 8q21. In situ RNA hybridizations of breast carcinoma sections indicated that the D52 gene was expressed in cancer cells, whereas other genes identified in the differential screening were expressed in fibroblastic or inflammatory cells within the tumor stroma. Thus, the procedure developed in this study selected genes expressed in a diversity of cell types, indicating its potential usefulness in other systems.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796418

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  Analysis of interaction partners for perilipin and ADRP on lipid droplets.

Authors:  Tomohiro Yamaguchi; Naoto Omatsu; Asami Omukae; Takashi Osumi
Journal:  Mol Cell Biochem       Date:  2006-03       Impact factor: 3.396

2.  Tumor protein D52 controls trafficking of an apical endolysosomal secretory pathway in pancreatic acinar cells.

Authors:  Scott W Messenger; Diana D H Thomas; Michelle A Falkowski; Jennifer A Byrne; Fred S Gorelick; Guy E Groblewski
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-18       Impact factor: 4.052

3.  Lentivirus-mediated TPD52L2 depletion inhibits the proliferation of liver cancer cells in vitro.

Authors:  Ze-Ya Pan; Yun Yang; Hao Pan; Jin Zhang; Hui Liu; Yuan Yang; Gang Huang; Lei Yin; Jian Huang; Wei-Ping Zhou
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Unique gene expression profile associated with an early-onset multiple endocrine neoplasia (MEN1)-associated pituitary adenoma.

Authors:  William E Farrell; Monalisa F Azevedo; Dalia L Batista; Alastair Smith; Isabelle Bourdeau; Anelia Horvath; Margaret Boguszewski; Martha Quezado; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

5.  DNA methylation in lung tissues of mouse offspring exposed in utero to polycyclic aromatic hydrocarbons.

Authors:  Trevor J Fish; Abby D Benninghoff
Journal:  Food Chem Toxicol       Date:  2017-05-02       Impact factor: 6.023

Review 6.  Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?

Authors:  Jennifer A Byrne; Sarah Frost; Yuyan Chen; Robert K Bright
Journal:  Tumour Biol       Date:  2014-05-06

7.  D53 is a novel endosomal SNARE-binding protein that enhances interaction of syntaxin 1 with the synaptobrevin 2 complex in vitro.

Authors:  Véronique Proux-Gillardeaux; Thierry Galli; Isabelle Callebaut; Anatoly Mikhailik; Georges Calothy; Maria Marx
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

8.  Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.

Authors:  Yoshiki Mukudai; Seiji Kondo; Atsushi Fujita; Yasuto Yoshihama; Tatsuo Shirota; Satoru Shintani
Journal:  Cell Oncol (Dordr)       Date:  2013-03-26       Impact factor: 6.730

9.  Dropping in on the lipid droplet- tumor protein D52 (TPD52) as a new regulator and resident protein.

Authors:  Yuyan Chen; Sarah Frost; Jennifer A Byrne
Journal:  Adipocyte       Date:  2016-03-22       Impact factor: 4.534

10.  Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival.

Authors:  Saied Mirshahidi; Victor G Kramer; James B Whitney; Sosthène Essono; Sandra Lee; Glenn Dranoff; Karen S Anderson; Ruth M Ruprecht
Journal:  Vaccine       Date:  2009-02-06       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.